Cargando…
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia
Autores principales: | Liang, Xinglin, Xia, Ruixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813551/ https://www.ncbi.nlm.nih.gov/pubmed/36524357 http://dx.doi.org/10.3892/or.2022.8463 |
Ejemplares similares
-
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia
por: Liang, Xinglin, et al.
Publicado: (2022) -
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling [Corrigendum]
Publicado: (2020) -
RhoA: A therapeutic target for chronic myeloid leukemia
por: Molli, Poonam R, et al.
Publicado: (2012) -
Dual efficacy of Fasudil at improvement of survival and reinnervation of flap through RhoA/ROCK/PI3K/Akt pathway
por: Wang, Hai, et al.
Publicado: (2022) -
A TRANSCRIPTIONAL CROSS–TALK BETWEEN RhoA AND c–Myc INHIBITS THE RhoA/Rock–DEPENDENT CYTOSKELETON
por: Sauzeau, Vincent, et al.
Publicado: (2010)